DE10138876B4 - Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung - Google Patents

Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung Download PDF

Info

Publication number
DE10138876B4
DE10138876B4 DE10138876A DE10138876A DE10138876B4 DE 10138876 B4 DE10138876 B4 DE 10138876B4 DE 10138876 A DE10138876 A DE 10138876A DE 10138876 A DE10138876 A DE 10138876A DE 10138876 B4 DE10138876 B4 DE 10138876B4
Authority
DE
Germany
Prior art keywords
camp
cng
concentration
channels
cng channels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10138876A
Other languages
German (de)
English (en)
Other versions
DE10138876A1 (de
Inventor
Ulrich B. Prof. Dr. Kaupp
Reinhard Dr. Seifert
Renate Dr. Gauß
Heinz-Gerd Dr. Körschen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forschungszentrum Juelich GmbH
Original Assignee
Forschungszentrum Juelich GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10138876A priority Critical patent/DE10138876B4/de
Application filed by Forschungszentrum Juelich GmbH filed Critical Forschungszentrum Juelich GmbH
Priority to EP02767329.2A priority patent/EP1414850B1/de
Priority to US10/486,316 priority patent/US7417117B2/en
Priority to JP2003519098A priority patent/JP4304064B2/ja
Priority to CA002456882A priority patent/CA2456882A1/en
Priority to PCT/EP2002/008756 priority patent/WO2003014149A2/de
Publication of DE10138876A1 publication Critical patent/DE10138876A1/de
Priority to US12/182,395 priority patent/US7951914B2/en
Application granted granted Critical
Publication of DE10138876B4 publication Critical patent/DE10138876B4/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE10138876A 2001-08-08 2001-08-08 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung Expired - Fee Related DE10138876B4 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE10138876A DE10138876B4 (de) 2001-08-08 2001-08-08 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung
US10/486,316 US7417117B2 (en) 2001-08-08 2002-08-06 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
JP2003519098A JP4304064B2 (ja) 2001-08-08 2002-08-06 遺伝子修飾された環状ヌクレオチド作動性イオンチャンネル及びその使用方法
CA002456882A CA2456882A1 (en) 2001-08-08 2002-08-06 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof
EP02767329.2A EP1414850B1 (de) 2001-08-08 2002-08-06 Genetisch modifizierte zyklisch-nukleotid-gesteuerte ionenkanäle und deren verwendung
PCT/EP2002/008756 WO2003014149A2 (de) 2001-08-08 2002-08-06 Genetisch modifizierte zyklisch-nukleotid-gesteuerte ionenkanäle und deren verwendung
US12/182,395 US7951914B2 (en) 2001-08-08 2008-07-30 Genetically modified cyclic-nucleotide controlled ion channels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10138876A DE10138876B4 (de) 2001-08-08 2001-08-08 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung

Publications (2)

Publication Number Publication Date
DE10138876A1 DE10138876A1 (de) 2003-03-06
DE10138876B4 true DE10138876B4 (de) 2008-11-06

Family

ID=7694756

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10138876A Expired - Fee Related DE10138876B4 (de) 2001-08-08 2001-08-08 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung

Country Status (6)

Country Link
US (2) US7417117B2 (enExample)
EP (1) EP1414850B1 (enExample)
JP (1) JP4304064B2 (enExample)
CA (1) CA2456882A1 (enExample)
DE (1) DE10138876B4 (enExample)
WO (1) WO2003014149A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DK1392359T4 (da) 2001-05-11 2013-06-10 Ludwig Inst For Cancer Res Ltd Specifikke bindingsproteiner og deres anvendelser.
DE10138876B4 (de) * 2001-08-08 2008-11-06 Forschungszentrum Jülich GmbH Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung
DE10311769A1 (de) * 2003-03-18 2004-09-30 Bayer Healthcare Ag Testmethoden zur Bestimmung der intrazellulären Konzentration zyklischer Nukleotide
ES2642262T3 (es) * 2009-06-30 2017-11-16 Otsuka Pharmaceutical Co., Ltd. Método de análisis biologico para anticuerpo contra el receptor de la hormona estimuladora tiroidea, kit de medición para el anticuerpo, y célula modificada genéticamente novedosa para su uso en el método de análisis biológico o en el kit de medición
SG191354A1 (en) * 2010-12-24 2013-07-31 Otsuka Pharma Co Ltd Bioassay method for detecting physiologically active substance

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042574A1 (de) * 1998-02-17 1999-08-26 Forschungszentrum Jülich GmbH Sequenzen eines ih-ionenkanals und deren verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001581A (en) 1993-06-04 1999-12-14 Sibia Neurosciences, Inc. Cation-based bioassay using human metabotropic glutamate receptors
AU7902398A (en) 1997-06-13 1999-01-04 Allelix Biopharmaceuticals Inc. Assay methods and compositions useful for measuring receptor ligand binding
DE10138876B4 (de) * 2001-08-08 2008-11-06 Forschungszentrum Jülich GmbH Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042574A1 (de) * 1998-02-17 1999-08-26 Forschungszentrum Jülich GmbH Sequenzen eines ih-ionenkanals und deren verwendung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALTENHOFEN,W., LUDWIG,J., EISMANN,E. [u.a.]: Con- trol of ligand specificity in cyclic nucliotide- gated channels from rod photoreceptors and olfac- tory epithelium. In: Proc. Natl. Acad. Sci. 1991, Vol.88., S.9868-9872.
ALTENHOFEN,W., LUDWIG,J., EISMANN,E. [u.a.]: Control of ligand specificity in cyclic nucliotidegated channels from rod photoreceptors and olfactory epithelium. In: Proc. Natl. Acad. Sci. 1991, Vol.88., S.9868-9872. *

Also Published As

Publication number Publication date
EP1414850A2 (de) 2004-05-06
WO2003014149A2 (de) 2003-02-20
DE10138876A1 (de) 2003-03-06
EP1414850B1 (de) 2013-06-19
WO2003014149A3 (de) 2003-10-09
US20060073468A1 (en) 2006-04-06
US20090104644A1 (en) 2009-04-23
US7417117B2 (en) 2008-08-26
CA2456882A1 (en) 2003-02-20
JP4304064B2 (ja) 2009-07-29
US7951914B2 (en) 2011-05-31
JP2005507245A (ja) 2005-03-17

Similar Documents

Publication Publication Date Title
DE69929993T4 (de) Nicht-endogene, konstitutiv aktivierte, menschliche, an ein g-protein gekoppelte rezeptoren
DE69230888T2 (de) Somatostatinrezeptoren
DE69431432T2 (de) Untereinheiten von menschlichen n-methyl-d-aspartat rezeptoren, diese kodierende nukleinsäure und dessen verwendung
DE69534741T2 (de) In hefe exprimierte heteologe g-protein-gekoppelte rezeptoren, fusionen desselben mit g-proteinen und deren verwendung im biotest
Tanaka et al. Structure and functional expression of the cloned rat neurotensin receptor
DE60125227T2 (de) Verfahren zum screening von diabetes-heilverfahren
DE69434166T2 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
DE69733933T2 (de) Neue Liganden des Neuropeptid Rezeptors HFGAN72
DE60119714T2 (de) Peptidderivat
DE69931360T2 (de) Neue, an ein g-protein gekoppelte rezeptorproteine
DE60207254T2 (de) Natürlicher ligand von gpcr chemr23 und dessen verwendung
CH694428A5 (de) GABA-B-Rezeptoren.
DE69132447T2 (de) Menschlicher dopamin d4 rezeptor und seine verwendungen
DE69935159T2 (de) Screening-verfahren
DE69636394T2 (de) Testverfahren für die sekretionsrezeptoren von wachstumshormonen
DE69906108T2 (de) Peptid-derivat
DE69534597T2 (de) Melatoninrezeptoren mit hoher affinität und ihre verwendungen
US7951914B2 (en) Genetically modified cyclic-nucleotide controlled ion channels
US5264565A (en) Nucleic acid encoding the D2 /Ml chimeric receptor
DE69633637T2 (de) Wachstumshormonsekretionsförderer rezeptorfamilie
DE69232953T2 (de) Gaba-a rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte zellen, die diese expremieren
DE69533796T2 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
DE60127435T2 (de) VERFAHREN ZUM SCREENEN EINES PLäTTCHENHEMMERS
DE69332715T2 (de) Transfektierte zelllinie, exprimierend dns die für die nmda-r2a rezeptor untereinheit und für isoformen der nmda-r1 untereinheit des menschlichen nmda-rezeptors kodieren
DE69535590T2 (de) Für den bradykinin-b1-rezeptor kodierende dna

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8181 Inventor (new situation)

Inventor name: K?RSCHEN, HEINZ-GERD, DR., 47804 KREFELD, DE

Inventor name: SEIFERT, REINHART, DR., 52428 JUELICH, DE

Inventor name: GAUSS, RENATE, DR., 40699 ERKRATH, DE

Inventor name: KAUPP, ULRICH B., PROF. DR., 52062 AACHEN, DE

8181 Inventor (new situation)

Inventor name: K?RSCHEN, HEINZ-GERD, DR., 47804 KREFELD, DE

Inventor name: SEIFERT, REINHARD, DR., 52428 JUELICH, DE

Inventor name: KAUPP, ULRICH B., PROF. DR., 52062 AACHEN, DE

Inventor name: GAUSS, RENATE, DR., 40699 ERKRATH, DE

8364 No opposition during term of opposition
R082 Change of representative
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20140301